Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.
Lode
H
H
Department of Chest and Infectious Diseases, Hospital Heckeshorn-Zehlendorf, Zum Heckeshorn 33, affil. Freie Universität Berlin, 14109 Berlin, Germany.
Eller
J
J
Raffenberg
M
M
Mauch
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002439:Cefotaxime / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002511:Cephalosporins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D002511:Cephalosporins; D002443:Ceftriaxone; D002439:Cefotaxime